Facilitating Safe Transition to Home for Preterm Infants - a National Database Study
- Disease/Condition
- Premature Birth
- Study type
- Observational
- Primary sponsor
- University Hospitals of Derby and Burton NHS Foundation Trust
- Location
- Derby, United Kingdom
- Phase
- N/A
- Start date
- Dec 01, 2023
- End date
- Nov 30, 2024
- Enrollment
- 250000 participants
Age and postmenstrual age when each of three physiological barriers are reached,Final barrier to discharge home
Preterm infants (i.e. born before 37 completed weeks of pregnancy) often require additional
 care and are admitted to neonatal units. Readiness for discharge home typically requires a
 level of physiological maturity, such that an infant is: 1) able to breathe spontaneously
 without additional support; 2) able to maintain body temperature; 3) able to take all
 nutritional requirements orally; 4) weighs ≥1700 grams and is consistently gaining weight.
 
 Staying in the hospital longer than necessary can be detrimental to infants, stressful for
 families, and costly to the NHS. Reducing the length of stay by just one day would be
 meaningful to parents and could save the UK National Health Service (NHS) almost £25million
 per year. Currently little is known about whether, how long and why preterm infants stay in
 hospital beyond the point at which they are physiologically ready for discharge.
 
 This study will use data from babies' medical records from the whole of England and Wales to
 identify the age and postmenstrual age when preterm infants reach each of the physiological
 barriers to discharge and identify which physiological discharge barrier requires preterm
 infants to remain in hospital the longest. The study will quantify the difference between the
 time preterm infants become physiologically ready for discharge and actual discharge home and
 describe factors associated with extended stays.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06284044
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06284044 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospitals of Derby and Burton NHS Foundation Trust and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 250000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.